UHT
Universal Health Realty Income Trust
NYSEUSDEQUITY
Real Estate
DELAYED
Sell
-43/100
Last price
37.42
▲ 0.50 (1.35%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
37.06
Prev close
36.92
Day high
37.53
Day low
36.74
Volume
146.41K
Market cap
$520.09M
P/E (TTM)
26.92
52W range
35.26 – 46.30
Day trading desk
Gap from prior close
+0.38%
Prior close 36.92
VWAP
37.36
+0.17% from price
Relative volume
2.29×
Unusually busy
Session range
2.26%
36.70 – 37.53
Position in range
87%
Near session high
ATR (14D)
0.92
2.46% of price
Prior day high
37.47
PDH
Prior day low
36.15
PDL
Bid / ask spread
—
Quote not published
Session volume
266.67K
Avg 116.60K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.55%
-3.5%
1M
-8.35%
-9.5%
3M
-14.37%
-18.9%
6M
-10.35%
-28.5%
YTD
-4.57%
-18.8%
1Y
-2.75%
-19.2%
3Y
-7.44%
-89.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on UHT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.16M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 10, 26 | MOREY JAMES P. Director |
STOCK | 819 | $0 | Direct |
| Jun 10, 26 | PETERSON KARLA J Officer |
STOCK | 1.60K | $0 | Direct |
| Jun 10, 26 | GUZMAN REBECCA A Director |
STOCK | 819 | $0 | Direct |
| Jun 10, 26 | BOYLE CHARLES F Chief Financial Officer |
STOCK | 3.63K | $0 | Direct |
| Jun 10, 26 | RAMAGANO CHERYL K Officer and Treasurer |
STOCK | 3.63K | $0 | Direct |
| Jun 10, 26 | MCCADDEN ROBERT F Director |
STOCK | 819 | $0 | Direct |
| Jun 10, 26 | DOMB MICHAEL ALLAN Director |
STOCK | 819 | $0 | Direct |
| Jun 10, 26 | CAPOZZALO GAYLE L. Director |
STOCK | 819 | $0 | Direct |
| Oct 29, 25 | MILLER ALAN B Chief Executive Officer |
BUY | 12.25K | $453.40K | Direct |
| Jun 11, 25 | MOREY JAMES P. Director |
STOCK | 821 | $0 | Direct |
| Jun 11, 25 | PETERSON KARLA J Officer |
STOCK | 1.54K | $0 | Direct |
| Jun 11, 25 | GUZMAN REBECCA A Director |
STOCK | 821 | $0 | Direct |
| Jun 11, 25 | BOYLE CHARLES F Chief Financial Officer |
STOCK | 3.50K | $0 | Direct |
| Jun 11, 25 | RAMAGANO CHERYL K Officer and Treasurer |
STOCK | 3.50K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BOYLE CHARLES F |
Chief Financial Officer | 47.40K | Stock Award(Grant) |
CAPOZZALO GAYLE L. |
Director | 5.17K | Stock Award(Grant) |
DOMB MICHAEL ALLAN |
Director | 13.17K | Stock Award(Grant) |
GUZMAN REBECCA A |
Director | 3.30K | Stock Award(Grant) |
MCCADDEN ROBERT F |
Director | 14.07K | Stock Award(Grant) |
MILLER ALAN B |
Chief Executive Officer | 224.10K | Purchase |
MILLER MARC D |
Director | 7.20K | Stock Award(Grant) |
MOREY JAMES P. |
Director | 4.77K | Stock Award(Grant) |
PETERSON KARLA J |
Officer | 6.18K | Stock Award(Grant) |
RAMAGANO CHERYL K |
Officer and Treasurer | 49.61K | Stock Award(Grant) |
Fundamentals
Market cap$520.09M
Enterprise value$905.77M
Revenue (TTM)$101.15M
Gross profit$95.48M
EBITDA$65.74M
Net income$19.27M
EPS (TTM)$1.39
Free cash flow$46.05M
Total cash$9.42M
Total debt$395.10M
Book value / share$10.35
Shares outstanding13.90M
Float12.77M
Short % of float4.38%
Dividend yield8.02%
Beta (5Y)0.85
Valuation & profitability ratios
Trailing P/E26.92
Forward P/E—
PEG ratio0.63
Price / sales—
Price / book3.61
EV / revenue8.95
EV / EBITDA13.78
Gross margin94.39%
Operating margin37.89%
Profit margin19.05%
Return on equity12.47%
Return on assets4.15%
Debt / equity274.55
Current ratio7.37
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $99.19M | $99.01M | $95.58M | $90.63M | +0.2% |
| Operating revenue | $96.50M | $96.72M | $93.07M | $87.43M | -0.2% |
| Cost of revenue | $5.59M | $5.48M | $5.32M | $5.10M | +2.1% |
| Gross profit | $93.59M | $93.53M | $90.25M | $85.53M | +0.1% |
| Total operating expense | $58.83M | $56.73M | $58.90M | $54.86M | +3.7% |
| Operating income | $34.76M | $36.80M | $31.35M | $30.67M | -5.5% |
| Net interest income | -$18.85M | -$18.84M | -$16.92M | -$10.76M | -0.0% |
| Pre-tax income | $17.61M | $19.23M | $15.40M | $21.10M | -8.4% |
| Net income | $17.61M | $19.23M | $15.40M | $21.10M | -8.4% |
| Net income to common | $17.61M | $19.23M | $15.40M | $21.10M | -8.4% |
| Basic EPS | 1.27 | 1.39 | 1.12 | 1.53 | -8.6% |
| Diluted EPS | 1.27 | 1.39 | 1.11 | 1.53 | -8.6% |
| EBIT | $38.72M | $43.07M | $32.32M | $31.86M | -10.1% |
| EBITDA | $67.58M | $70.49M | $60.06M | $58.41M | -4.1% |
| Basic shares | 13.82M | 13.80M | 13.79M | 13.77M | +0.1% |
| Diluted shares | 13.86M | 13.84M | 13.81M | 13.79M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $6.69M | $7.10M | $8.21M | $7.61M | -5.8% |
| Cash & short-term investments | $6.69M | $7.10M | $8.21M | $7.61M | -5.8% |
| Accounts receivable | $15.56M | $15.11M | $14.35M | $13.83M | +3.0% |
| Total current assets | $104.40M | $105.00M | $105.84M | $105.05M | -0.6% |
| Property, plant & equipment | $11.39M | $10.92M | $10.95M | $11.46M | +4.4% |
| Goodwill & intangibles | $5.64M | $7.33M | $9.11M | $9.45M | -23.0% |
| Total assets | $564.91M | $580.86M | $596.37M | $607.54M | -2.7% |
| Total current liabilities | $370.89M | $360.04M | $340.59M | $311.35M | +3.0% |
| Current debt | $356.20M | $348.90M | $326.60M | $298.10M | +2.1% |
| Long-term debt | $18.43M | $19.35M | $32.86M | $44.73M | -4.7% |
| Total debt | $386.03M | $379.17M | $370.41M | $354.28M | +1.8% |
| Total liabilities | $412.52M | $401.32M | $395.44M | $378.44M | +2.8% |
| Retained earnings | $862.90M | $845.29M | $826.06M | $810.66M | +2.1% |
| Shareholder equity | $152.38M | $179.54M | $200.93M | $229.10M | -15.1% |
| Working capital | -$266.50M | -$255.04M | -$234.75M | -$206.30M | -4.5% |
| Net tangible assets | $146.74M | $172.22M | $191.82M | $219.65M | -14.8% |
| Shares issued | 13.87M | 13.85M | 13.82M | 13.80M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $17.61M | $19.23M | $15.40M | $21.10M | — | -8.4% |
| Depreciation & amortisation | $28.69M | $27.25M | $27.59M | $26.41M | — | +5.3% |
| Stock-based compensation | $936.00K | $853.00K | $780.00K | $780.00K | — | +9.7% |
| Change in working capital | $2.98M | $82.00K | $16.00K | -$228.00K | — | +3,536.6% |
| Operating cash flow | $49.09M | $46.91M | $42.94M | $46.80M | — | +4.6% |
| Capital expenditure | — | — | -$7.62M | -$13.62M | -$12.99M | — |
| Investing cash flow | -$14.96M | -$13.88M | -$19.11M | -$36.67M | — | -7.8% |
| Share buybacks | — | -$131.00K | — | $0 | $0 | — |
| Dividends paid | -$41.03M | -$40.39M | -$39.77M | -$39.18M | — | -1.6% |
| Financing cash flow | -$34.55M | -$34.15M | -$23.23M | -$25.02M | — | -1.2% |
| Free cash flow | $49.09M | $46.91M | $42.94M | $46.80M | — | +4.6% |
| End cash position | $6.69M | $7.10M | $8.21M | $7.61M | — | -5.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $24.99M | $24.53M | $24.47M | $25.30M | $24.87M | +1.9% |
| Operating revenue | $24.14M | $23.93M | $23.70M | $24.49M | $24.30M | +0.9% |
| Cost of revenue | $1.43M | $1.40M | $1.43M | $1.41M | $1.39M | +1.8% |
| Gross profit | $23.56M | $23.13M | $23.05M | $23.89M | $23.48M | +1.9% |
| Total operating expense | $14.36M | $14.17M | $14.55M | $15.49M | $14.63M | +1.3% |
| Operating income | $9.20M | $8.96M | $8.49M | $8.39M | $8.84M | +2.8% |
| Net interest income | -$4.95M | -$4.96M | -$2.30M | -$5.61M | -$5.50M | +0.3% |
| Pre-tax income | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | +17.7% |
| Net income | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | +17.7% |
| Net income to common | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | +17.7% |
| Basic EPS | 0.43 | 0.36 | 0.31 | 0.29 | 0.33 | +19.4% |
| Diluted EPS | 0.43 | 0.36 | 0.31 | 0.29 | 0.32 | +19.4% |
| EBIT | $10.71M | $9.81M | $9.45M | $9.44M | $9.80M | +9.1% |
| EBITDA | $17.74M | $16.77M | $16.57M | $17.34M | $16.80M | +5.8% |
| Basic shares | 13.84M | 13.83M | 13.83M | 13.83M | 13.81M | +0.0% |
| Diluted shares | 13.88M | 13.88M | 13.87M | 13.87M | 13.86M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.82M | $7.06M | $6.69M | $6.92M | $6.55M | -3.5% |
| Cash & short-term investments | $6.82M | $7.06M | $6.69M | $6.92M | $6.55M | -3.5% |
| Accounts receivable | $15.47M | $15.45M | $15.56M | $15.71M | $15.33M | +0.1% |
| Total current assets | $104.03M | $104.46M | $104.40M | $118.70M | $117.35M | -0.4% |
| Property, plant & equipment | $11.38M | $11.39M | $11.39M | $10.90M | $10.90M | -0.1% |
| Goodwill & intangibles | $4.87M | $5.25M | $5.64M | $6.04M | $6.46M | -7.3% |
| Total assets | $567.12M | $563.76M | $564.91M | $568.04M | $573.02M | +0.6% |
| Total current liabilities | $381.52M | $374.00M | $370.89M | $369.17M | $367.08M | +2.0% |
| Current debt | $365.55M | $359.50M | $356.20M | $357.05M | $354.80M | +1.7% |
| Long-term debt | $18.15M | $18.29M | $18.43M | $18.57M | $18.71M | -0.8% |
| Total debt | $395.10M | $389.19M | $386.03M | $386.52M | $384.42M | +1.5% |
| Total liabilities | $423.21M | $415.96M | $412.52M | $409.46M | $407.86M | +1.7% |
| Retained earnings | $873.83M | $867.92M | $862.90M | $858.58M | $854.56M | +0.7% |
| Shareholder equity | $143.91M | $147.80M | $152.38M | $158.57M | $165.15M | -2.6% |
| Working capital | -$277.49M | -$269.54M | -$266.50M | -$250.46M | -$249.73M | -3.0% |
| Net tangible assets | $139.03M | $142.55M | $146.74M | $152.53M | $158.69M | -2.5% |
| Shares issued | 13.90M | 13.88M | 13.87M | 13.87M | 13.87M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | +17.7% |
| Depreciation & amortisation | $6.99M | $6.91M | $7.07M | $7.86M | $6.95M | +1.1% |
| Stock-based compensation | $203.00K | $190.00K | $274.00K | $236.00K | $213.00K | +6.8% |
| Change in working capital | $213.00K | $8.00K | $2.24M | -$1.79M | $2.35M | +2,562.5% |
| Operating cash flow | $12.40M | $11.95M | $13.60M | $10.20M | $13.69M | +3.8% |
| Investing cash flow | -$7.84M | -$4.46M | -$2.52M | -$1.75M | -$8.79M | -75.9% |
| Dividends paid | -$10.52M | -$10.30M | -$10.31M | -$10.23M | -$10.33M | -2.1% |
| Financing cash flow | -$4.81M | -$7.12M | -$11.30M | -$8.09M | -$5.32M | +32.4% |
| Free cash flow | $12.40M | $11.95M | $13.60M | $10.20M | $13.69M | +3.8% |
| End cash position | $6.82M | $7.06M | $6.69M | $6.92M | $6.55M | -3.5% |
Options analytics
Put / call volume
0.33
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
35.00
-6.5% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
30
Contracts, this expiry
Put volume
10
Contracts, this expiry
Heaviest call OI
35.00
0 contracts
Heaviest put OI
35.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $24.90M | -1.6% |
| Next quarter | — | — | $25.10M | +2.6% |
| Current year | — | — | $99.50M | +0.3% |
| Next year | — | — | $104.70M | +5.2% |
Analyst targets & ownership
Mean target$44.00
High target$44.00
Low target$44.00
Implied upside17.58%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 0
Hold1
Sell / Strong sell0 / 0
Held by insiders8.36%
Held by institutions63.45%
Institutions holding264
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
37.73
-0.82% from price
SMA 20
39.03
-4.13% from price
SMA 50
40.71
-8.08% from price
SMA 100
41.31
-9.42% from price
SMA 200
41.30
-9.39% from price
EMA 12
37.96
-1.43% from price
EMA 26
39.09
-4.28% from price
EMA 50
40.11
-6.70% from price
RSI (14)
34.4
Neutral
MACD (12,26,9)
-1.13
Hist -0.17
ATR (14)
0.92
2.46% of price
Realised vol 30D
17.9%
Annualised
Bollinger upper
42.09
20, 2σ
Bollinger lower
35.97
20, 2σ
50 / 200 cross
Death
40.71 vs 41.30
Trend bias
Below 200
-9.39%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.06
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
17.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-20.5%
Peak to trough
Max drawdown 5Y
-46.7%
Peak to trough
ATR 14
0.92
2.46% of price
Beta (reported)
0.85
5Y monthly, from filing
Short interest
Shares short
433.81K
Prior 369.47K
Change vs prior
+17.4%
Shorts adding
% of float
4.38%
Normal
% of shares out
3.12%
Against total outstanding
Days to cover
4.4
Liquid
Float
12.77M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 12, 25 | Freedom Broker | MAINTAINED | Hold | Hold |
Dividends & splits
Forward rate$3.00 / yr
Forward yield8.02%
5-year avg yield6.44%
Payout ratio214.39%
Ex-dividend dateSep 21, 2026
Next pay dateSep 30, 2026
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-07-27
Corporate Changes & Voting Matters
8-K · 2026-06-11
Periodic Financial Reports
10-Q · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-04-27
Corporate Changes & Voting Matters
8-K · 2026-04-24
Corporate Changes & Voting Matters
8-K · 2026-02-25
Headlines
Universal Health Realty Income Trust's Dividend Analysis
GuruFocus.com · 16d ago
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND
PR Newswire · 28d ago
Universal Health Realty Stock Gains Post Q2 Earnings, FFO Improves
Zacks · 69d ago
Universal Health Realty: Q2 Earnings Snapshot
Associated Press · 71d ago
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026
PR Newswire · 71d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.